Sign In
Buy ELTP
$0.381
-0.0189 (-4.73%)
At Close: Jun 05, 2026
Financials for Second Quarter Fiscal Year 2024 Ended September 30, 2023 will be released on November 14, 2023 NORTHVALE, NJ / ACCESSWIRE / November 10, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or t
7 Penny Stocks With Promising Potential Catalysts in 2024
07:21am, Thursday, 09'th Nov 2023
Navigating the stock market's murky waters, the forecast for promising penny stocks might seem overcast. Within this realm, though, certain names are bucking the trend, boasting robust performances th
Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024
06:30am, Monday, 09'th Oct 2023
When it comes to stock predictions and penny stocks to buy, admittedly the near-term picture remains cloudy. Right now, it's unclear whether high interest rates, high inflation, and the still-present
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
06:00am, Monday, 25'th Sep 2023
NORTHVALE, NJ / ACCESSWIRE / September 25, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and di
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
06:00am, Thursday, 07'th Sep 2023
NORTHVALE, NJ / ACCESSWIRE / September 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic prod
7 Up-and-Coming Penny Stocks to Put on Your Must-Buy List
06:50am, Monday, 04'th Sep 2023
“Penny stock territory” may be chock full of “fallen angels,” former high-fliers, along with shares in companies with minimal growth prospects, but among the thousands of publicly-traded stock
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
06:00am, Monday, 28'th Aug 2023
NORTHVALE, NJ / ACCESSWIRE / August 28, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and distr
Elite Pharmaceuticals, Inc. (ELTP) Q1 2024 Earnings Call Transcript
03:55pm, Tuesday, 15'th Aug 2023
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2024 Results Conference Call August 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Operator Good morning, la
Financials for First Quarter Fiscal Year 2024 Ended June 30, 2023 will be released on August 14, 2023 NORTHVALE, NJ / ACCESSWIRE / August 9, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information
05:10pm, Thursday, 29'th Jun 2023
Conference Call Scheduled for Friday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutic
Financials for Fiscal Year 2023 Ended March 31, 2023 will be released on June 29, 2023 NORTHVALE, NJ / ACCESSWIRE / June 22, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP),
7 OTC Stocks to Buy With Boatloads of Potential
08:41pm, Wednesday, 07'th Jun 2023
Whether you're a growth investor, a value investor, or something in-between, the over-the-counter (or OTC) market is a great place to look for opportunities. Even though many carry higher risk, there
Elite Pharmaceuticals, Inc. (ELTP) Q3 2023 Earnings Call Transcript
03:48pm, Wednesday, 15'th Feb 2023
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q3 2023 Earnings Conference Call February 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Robert Chen - Chief Fi
Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty p
Financials for Third Quarter Fiscal Year 2023 Ended December 31, 2022 will be released on February 14, 2023 NORTHVALE, NJ / ACCESSWIRE / February 8, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the
